Thailand Veterinary Contract Manufacturing & Research Market (2026-2031)
The Thailand Veterinary Contract Manufacturing & Research Market was valued at $13.1 Million in 2026 and projected to reach to $18.9 Million by 2031, representing a compound annual growth rate of 7.6%. Thailand's veterinary contract manufacturing and research market is positioned for robust growth through 2031, with a CAGR of 7.6% reflecting increasing regional demand for outsourced pharmaceutical solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Thailand Veterinary Contract Manufacturing & Research Market Trends and Insights
- Thailand is emerging as a key hub for veterinary pharmaceutical outsourcing in Southeast Asia, driven by increasing demand for cost-effective manufacturing solutions and growing livestock production.
- The market in Thailand benefits from the country's established pharmaceutical infrastructure, skilled workforce, and strategic geographic position within the Asia Pacific region. Thailand's veterinary contract manufacturing sector is experiencing accelerated growth due to rising pet ownership, expanding aquaculture and poultry industries, and heightened regulatory focus on animal health.
- Between 2026 and 2031, Thailand is expected to capture growing market share as regional and international pharmaceutical companies establish or expand manufacturing partnerships.
- Thailand's competitive advantages in labor costs, regulatory compliance capabilities, and proximity to major Asian markets position the country as an attractive destination for veterinary research and manufacturing outsourcing..
Key Market Statistics
- CAGR (2026-2031) 7.6% CAGR
- Market Size, 2026 ~USD 13.1 Million
- Forecast, 2031 ~USD 18.9 Million
- Country Thailand
Thailand Veterinary Contract Manufacturing & Research Market Overview
Market Valuation Growth :
Thailand's veterinary contract manufacturing and research market is valued at USD 13.1 million in 2026 and is projected to reach USD 18.9 million by 2031, demonstrating strong regional expansion potential.
Southeast Asia Hub Status :
Thailand is emerging as a critical outsourcing destination in Southeast Asia for veterinary pharmaceutical manufacturing, leveraging competitive labor costs and established regulatory frameworks to attract international partnerships.
Cost-Effective Manufacturing Solutions :
The country's growing reputation for cost-effective veterinary drug manufacturing is driving increased demand from global pharmaceutical companies seeking to optimize production expenses without compromising quality standards.
Livestock Industry Expansion :
Thailand's expanding livestock and aquaculture sectors are fueling demand for veterinary pharmaceuticals and contract research services, creating sustained growth opportunities for manufacturing and development facilities.
Thailand Veterinary Contract Manufacturing & Research Market Dynamics
- The country's competitive manufacturing costs, improving regulatory infrastructure, and strategic location within Southeast Asia make it an attractive destination for global veterinary pharmaceutical companies seeking to establish or expand production capabilities.
- Growing livestock farming and aquaculture industries further support market expansion.
- Investment in advanced manufacturing facilities and research capabilities will be critical to capturing emerging opportunities in the region..
Related Ecosystem
Animal Health
Key Takeaways
- Thailand's veterinary contract manufacturing market is valued at USD 13.1 million in 2026 and will grow to USD 18.9 million by 2031 at a 7.6% CAGR.
- Thailand is positioned as a cost-competitive outsourcing destination for veterinary pharmaceutical manufacturing in the Asia Pacific region.
- Rising pet ownership and expanding livestock industries in Thailand are driving demand for veterinary contract research and manufacturing services.
- Thailand's established regulatory framework and pharmaceutical infrastructure support long-term market expansion through 2031.
Veterinary Contract Manufacturing & Research Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CDMO SERVICES (Service) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.7% from 2026 to 2031 |
| Largest Segment | CDMO SERVICES (Service) |
| Market Size Base Year (Billions) | ~USD 6.38 (2026) |
| Revenue Forecast (Billions) | ~USD 9.24 (2031) |
| Segments Covered | Service, Type |
Thailand Veterinary Contract Manufacturing & Research Market Report Segmentation
2 segment dimensions are covered across the global market.
By Service
- Cdmo Services
- Cro Services
By Type
- Analytical & Bioanalytical Services And Quality Assurance
- Discovery & Pre-Clinical Studies
- Manufacturing
- Packaging & Labeling
- Process Api & Formulation Development
- Quality/Stability & Post-Market Support
- Regulatory Affairs & Consulting
- Veterinary Clinical Trials
THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS | 5.3 | 5.7 | 6.2 | 6.6 | 7.2 | 7.7 | 8.3 | 9 | 7.9 |
| MULTINATIONAL ANIMAL HEALTH COMPANIES | 3.6 | 3.8 | 4 | 4.2 | 4.4 | 4.6 | 4.8 | 5 | 4.9 |
| START-UPS & VETERINARY BIOTECH FIRMS | 2.4 | 2.7 | 3 | 3.3 | 3.6 | 4 | 4.4 | 4.9 | 10.4 |
| TOTAL | 11.3 | 12.2 | 13.1 | 14.1 | 15.2 | 16.3 | 17.6 | 18.9 | 7.6 |
Target Audience
- Pharmaceutical Manufacturers : Global and regional veterinary pharmaceutical companies seeking cost-effective contract manufacturing solutions and outsourcing opportunities in Thailand's growing market.
- Contract Research Organizations : CROs and research institutions evaluating Thailand as a location for veterinary drug development, clinical trials, and regulatory support services.
- Investment & Private Equity Firms : Investors analyzing Thailand's veterinary healthcare sector for acquisition targets, joint ventures, and capital deployment opportunities in emerging Southeast Asian markets.
- Livestock & Aquaculture Companies : Animal agriculture businesses requiring veterinary pharmaceutical products and contract manufacturing services to support Thailand's expanding livestock and aquaculture operations.
- Government & Trade Organizations : Thai government agencies, trade bodies, and economic development organizations seeking market intelligence to promote veterinary manufacturing capabilities and attract foreign investment.
Reasons to Buy this Report
- Market Entry Strategy : Gain comprehensive insights into Thailand's veterinary manufacturing landscape to develop effective market entry strategies and identify optimal partnership opportunities with local contract manufacturers.
- Competitive Benchmarking : Understand Thailand's cost structure, manufacturing capabilities, and competitive positioning relative to other Southeast Asian countries to make informed outsourcing decisions.
- Growth Opportunity Assessment : Evaluate the 7.6% CAGR growth trajectory and identify high-potential segments within Thailand's veterinary pharmaceutical market for expansion and investment planning.
- Regulatory & Operational Insights : Access detailed information on Thailand's regulatory environment, quality standards, and operational requirements specific to veterinary contract manufacturing and research activities.
- Supply Chain Optimization : Leverage market intelligence to optimize your veterinary pharmaceutical supply chain by identifying reliable manufacturing partners and understanding local production capabilities and timelines.
Frequently asked questions
What is the current market size of veterinary contract manufacturing in Thailand?
Thailand's veterinary contract manufacturing and research market is valued at USD 13.1 million in 2026.
What is the projected market size for Thailand's veterinary contract manufacturing by 2031?
Thailand's veterinary contract manufacturing market is projected to reach USD 18.9 million by 2031.
What is the CAGR for Thailand's veterinary contract manufacturing market?
Thailand's veterinary contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2031.
What factors are driving growth in Thailand's veterinary contract manufacturing sector?
Key growth drivers in Thailand include rising pet ownership, expanding aquaculture and poultry industries, increased regulatory focus on animal health, and Thailand's competitive manufacturing costs.
Why is Thailand attractive for veterinary contract manufacturing outsourcing?
Thailand offers cost-competitive manufacturing, established pharmaceutical infrastructure, skilled workforce, regulatory compliance capabilities, and strategic geographic proximity to major Asian markets.
RESEARCH METHODOLOGY
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Other designations include sales, marketing, and product/service managers.
Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.
Market Definition
The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.
These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.
Key Stakeholders
- Animal-health pharmaceutical companies
- Veterinary biotechnology companies
- Veterinary biologics & vaccine developers
- Veterinary contract development & manufacturing organizations (CDMOs)
- Veterinary contract research organizations (CROs)
- Preclinical & toxicology research laboratories (GLP & non-GLP)
- Clinical trial management organizations for veterinary studies
- Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
- Quality control & analytical testing laboratories (veterinary-focused)
- Veterinary formulation & process development service providers
- Packaging, filling, and labeling service providers for veterinary products
- Animal research facilities & field trial centers
- Veterinary academic research institutes
- Livestock research institutions & herd-health trial networks
- Raw material suppliers for veterinary APIs, excipients, and biologics components
Report Objectives
- To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
- Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
- Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
- Competitive leadership mapping for established players in the US
Get the Full Veterinary Contract Manufacturing & Research Market Report
Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.
- US Veterinary Contract Manufacturing & Research Market
- Canada Veterinary Contract Manufacturing & Research Market
- Mexico Veterinary Contract Manufacturing & Research Market
- Brazil Veterinary Contract Manufacturing & Research Market
- Argentina Veterinary Contract Manufacturing & Research Market
- Germany Veterinary Contract Manufacturing & Research Market
- UK Veterinary Contract Manufacturing & Research Market
- France Veterinary Contract Manufacturing & Research Market
- Italy Veterinary Contract Manufacturing & Research Market
- Spain Veterinary Contract Manufacturing & Research Market
- Netherlands Veterinary Contract Manufacturing & Research Market
- China Veterinary Contract Manufacturing & Research Market
- Japan Veterinary Contract Manufacturing & Research Market
- India Veterinary Contract Manufacturing & Research Market
- Australia Veterinary Contract Manufacturing & Research Market
- South Korea Veterinary Contract Manufacturing & Research Market
- New Zealand Veterinary Contract Manufacturing & Research Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report